Form 8-K - Current report:
SEC Accession No. 0001619856-24-000080
Filing Date
2024-11-06
Accepted
2024-11-06 16:07:33
Documents
15
Period of Report
2024-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbu-20241106.htm   iXBRL 8-K 27412
2 EX-99.1 crbu-20241106xexx991.htm EX-99.1 85600
6 img25401123_0.jpg GRAPHIC 52289
  Complete submission text file 0001619856-24-000080.txt   328379

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20241106.xsd EX-101.SCH 1791
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20241106_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20241106_pre.xml EX-101.PRE 13587
17 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20241106_htm.xml XML 2916
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40631 | Film No.: 241430937
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)